Agency Information Collection Activities; Orphan Drugs: Submission for OMB Review; Comment Request

الملخص

The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA).